Company Filing History:
Years Active: 2013-2014
Title: The Innovations of Neil Hyde
Introduction
Neil Hyde is a notable inventor based in Hull, GB. He has made significant contributions to the field of medicinal compositions, particularly in the development of analgesic treatments. With a total of 3 patents to his name, Hyde's work has the potential to impact pain management therapies.
Latest Patents
Hyde's latest patents include a medicinal composition comprising buprenorphine and naltrexone. This innovative analgesic composition is designed for parenteral unit dosage form or for delivery via the dermis or mucosa. The formulation ensures that the ratio by weight of buprenorphine to naltrexone delivered to or reaching the plasma of a patient is in the range of 100:1 to 5000:1. The analgesic action of buprenorphine is enhanced by the low dose of naltrexone. Additionally, he has developed a pack of medicinal tablets that is water- and oxygen-occlusive. This pack encloses an inert atmosphere containing medicinal tablets, wherein the tablets consist of buprenorphine or a salt or ester thereof.
Career Highlights
Throughout his career, Neil Hyde has worked with reputable companies such as Rb Pharmaceuticals Limited and Indivior UK Limited. His experience in these organizations has contributed to his expertise in the pharmaceutical industry and the development of innovative medicinal products.
Collaborations
Hyde has collaborated with notable individuals in his field, including Christopher Bourne Chapleo and Graham Cairns. These collaborations have likely enriched his work and contributed to the advancements in his patented inventions.
Conclusion
Neil Hyde's contributions to medicinal compositions and pain management highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to advancing therapeutic options for patients in need.